Under the structure of the transaction, the aggregate investment amount will be up to $15 million invested in two tranches of $7.5 million each and divided among a group of investors in varying percentages. The agreement provides up to $15 million for further investment capital and will facilitate the company’s efforts to implement an American Depository Receipt program on a U.S. stock exchange.
More Articles on Orthopedic Devices:
pinal Elements to Donate Allograft Proceeds to Charity
Medtronic Launches Complementary Instrument Set for BRYAN Cervical Disc
SkelRegen Forms With Focus on Musculoskeletal Care
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.